Vicki L Sato is of Allogene Therapeutics, Inc.. Currently has a direct ownership of 162,575 shares of ALLO, which is worth approximately $356,039. The most recent transaction as insider was on Jun 05, 2024, when has been sold 61,475 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 163K
0% 3M change
60.81% 12M change
Total Value Held $356,039

VICKI L SATO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2024
BUY
Grant, award, or other acquisition
-
61,475 Added 27.44%
162,575 Common Stock
Jun 13 2023
BUY
Grant, award, or other acquisition
-
59,649 Added 37.11%
101,100 Common Stock
Jun 15 2022
BUY
Grant, award, or other acquisition
-
22,089 Added 34.76%
41,451 Common Stock
Jul 30 2021
BUY
Grant, award, or other acquisition
-
19,362 Added 50.0%
19,362 Common Stock

Also insider at

BMY
BRISTOL MYERS SQUIBB CO Healthcare
DNLI
Denali Therapeutics Inc. Healthcare
VIR
Vir Biotechnology, Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
VLS

Vicki L Sato

New York, NY

Track Institutional and Insider Activities on ALLO

Follow Allogene Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

News

Receive news related to Allogene Therapeutics, Inc.

Track Activities on ALLO